Bengaluru, July 16 -- The shares of this small-cap stock that engaged in the business of offering bio-based Chemicals, pharmaceuticals, and others are in focus after getting approval for compounds used for cancer treatment.

With a market capitalization of Rs. 1,543 Crores, the shares of Godavari Biorefineries Limited opened at Rs. 301.50 per equity share, from its previous day's closing price of Rs. 287.15.

Patent Details Godavari Biorefineries Limited has received a significant boost with the grant of a new patent by the China National Intellectual Property Administration (CNIPA). The patent, titled "5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER", covers a novel compound found to be effective in fighting cancer and ...